Financial Analysis

Doosan Robotics (454910.KS) Q1 2026: Revenue Nearly Triples as Consolidated Operating Loss Holds at ₩12.1B

Amorepacific (090430.KS) Q1 2026: Domestic Profit Surges 65%, COSRX Overseas Down 18%

Yuhan (000100.KS) Q1 2026: Net Profit +134% on Non-Op Windfall

Yuhan (000100.KS) Q1 2026: Net Profit +134% on Non-Op Windfall *Equity method gains and financial income power the headline profit surge; lazertinib advances to five-market approval while core operati

GS (078930.KS) Q1 2026: Profit Surges 3.5× on Caltex Equity Boom

GS Holdings (078930.KS) Q1 2026 controlling shareholder net income surged 3.5× YoY to ₩723.2B, driven by one-off inventory gains from a Hormuz-driven crude spike amplifying GS Caltex's equity contribution.

Hanwha Solutions (009830.KS) Q1 2026: ₩92.6B Operating Swing as Chemicals Rebound, Qcells Profit Halves

Hanwha Solutions posted consolidated operating profit of ₩92.6 billion in Q1 2026, a 205.5% year-on-year surge from ₩30.3 billion, ending a two-year operating loss streak that had consumed ₩1.37 trill

Daeduck (008060.KS) Q1 2026: AI Substrates Flip Profit to ₩51.3B

LG Display (034220.KS) Q1 2026: Operating Profit Surges 4.4x as ₩13.7T Debt Swells Net Loss to ₩575.7B

LG Display (034220.KS) Q1 2026: Profit 4× but ₩576B Net Loss Bites

SK Biopharma (326030.KS) Q1 2026: Cenobamate Lifts Operating Profit 250%, Margin Hits 39%

Single-drug operating leverage transforms SK Biopharmaceuticals from loss-making drug launcher to high-margin cash generator — operating margin more than doubles year-over-year.

Hankook Tire (161390.KS) Q1 2026: Margin Hits 9.5%, Operating Profit Surges 43%

Hanjin KAL (180640.KS) Q1 2026: +17% Profit Hides 69% Equity Income Drop

DB HiTek (000990.KS) FY2025: 45% Profit Surge, 8-Inch Fab at 92%